TGTX

TG Therapeutics, Inc.

TGTX·88322Q108·US·Common Stock·Healthcare - Biotechnology-13D/G

TGTX (TG Therapeutics, Inc.) is held by 182 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.2B), VANGUARD PORTFOLIO MANAGEMENT LLC ($437.5M), STATE STREET CORP ($427.8M). Net institutional sentiment: Mixed.

182
Holders
(10 Elite)
$5.4B
Total Value
63% (185)
Consensus
117 buying - 68 selling
13F: Insider & Congress: Updated regularly
TGTX

Smart Money Verdict

View all
Loading verdict
Held by 182 funds
10 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Nov 25, 2025 · Activists Apr 29, 2026 · Congress none

ActivistVPVanguard Portfolio Management5.3%Apr 29, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderEYEchelard YannSell $163KNov 24, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
22.1M(-0.9%)$1.2B0.0%+75.11%
0
Decreased
8M(-3.8%)$437.5M0.0%+90.55%
0
Decreased
7.8M(-10.0%)$427.8M0.0%+161.53%
0
Decreased
6.1M(-6.9%)$337.8M0.0%+90.55%
0
Increased
3.6M(+4.1%)$200.1M0.0%+159.77%
32
Increased
3.4M(+476.4%)$186.8M0.1%+8.51%
49
Decreased
2.7M(-17.5%)$145.6M0.1%+56.25%
0
Increased
2.6M(+19.9%)$142.9M0.9%+62.55%
51
Increased
2.5M(+60.1%)$135.6M0.1%+44.86%
43
Increased
2.3M(+1.2%)$127.1M0.0%+71.68%
30
Increased
1.8M(+2.2%)$98.1M0.1%+193.54%
31
Decreased
1.8M(-14.2%)$96.3M0.0%+67.52%
0
Increased
1.6M(+12.4%)$89.3M0.0%+50.46%
34
Increased
1.6M(+13.7%)$88M0.0%+116.31%
34
Increased
1.6M(+2.0%)$87.9M0.6%+200.17%
43
Increased
1.5M(+6.5%)$84.4M0.0%+225.55%
32
Increased
1.3M(+1.4%)$72.1M0.0%+193.32%
30
Decreased
1.3M(-10.4%)$72M0.0%+69.34%
0
Increased
1.2M(+11.6%)$66.5M0.0%+71.55%
33
Increased
1M(+263.3%)$56M0.0%+12.07%
47

Showing 1-20 of 190

1 / 10
TGTXTGTXTG Therapeutics, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used